Detalles de la búsqueda
1.
Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis.
Int J Cancer
; 154(7): 1272-1284, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151776
2.
Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways.
Gastric Cancer
; 27(3): 506-518, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386237
3.
High Preoperative Platelet to Lymphocyte Ratio Is Associated with a Greater Risk of Postoperative Complications and Hematogenous Recurrences in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Treatment.
Dig Surg
; 40(1-2): 48-57, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36893749
4.
The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset.
Dig Surg
; 37(2): 135-144, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-30840952
5.
OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus.
Cancer Genomics Proteomics
; 20(4): 343-353, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400143
6.
Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer.
Histol Histopathol
; 36(8): 817-832, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33719028
7.
Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer.
Anticancer Res
; 41(2): 609-617, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33517265
Resultados
1 -
7
de 7
1
Próxima >
>>